IL1B and colitis: In addition, the administration of apelin to Il10−/− mice with established colitis resulted not only in an amelioration of disease by lowering the production of pro-inflammatory cytokines such as TNFα, IL-6, and IL-1β but furthermore enhanced intestinal lymphatic function.